Celldex Therapeutics, Inc.
Agonistic antibodies that bind CD40

Last updated:

Abstract:

Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.

Status:
Grant
Type:

Utility

Filling date:

5 Apr 2019

Issue date:

28 Apr 2020